Possible role of Streptococcus pyogenes in mucocutaneous lymph node syndrome. XII. Variable responses of platelets in MCLS seem to be explainable by streptococcal pyrogenic exotoxin.
As a model system for mucocutaneous lymph node syndrome (MCLS), we have advocated and used mice which had been rendered tolerant to Streptococcus pyogenes-associated antigens by neonatal infection with group A beta-hemolytic streptococci, because these mice have shown a variety of peculiar bioimmunological characteristics bearing a striking resemblance to those of MCLS patients. The results of our current investigations reaffirmed the reliability of the animal model by indicating that mice subjected to neonatal infection with S. pyogenes, or inoculation with streptococcal pyrogenic exotoxin (SPE) in Freund's adjuvant, were perfect counterparts of patients with MCLS on account of their platelet activation and hyperaggregability in response to provocative treatment, which are familiar findings in this disease.
Akiyama
T
T
Department of Microbiology, Kitasato University School of Medicine, Sagamihara, Japan.
Osawa
N
N
Shimanuki
K
K
Yashiro
K
K
Oyake
T
T
D000818:Animals; D000831:Animals, Newborn; D004195:Disease Models, Animal; D005098:Exotoxins / Q000276:immunology*; D005260:Female; D008297:Male; D051379:Mice; D009080:Mucocutaneous Lymph Node Syndrome / Q000097:blood / Q000276:immunology*; D015539:Platelet Activation / Q000187:drug effects / Q000276:immunology; D010974:Platelet Aggregation; D010976:Platelet Count; D013297:Streptococcus pyogenes / Q000276:immunology*
D005098:Exotoxins